NervGen Pharma Corp NGENNasdaq
1.7USDClose on 08/10
At a glance
NervGen Pharma Corp sits in the ‘Resting’ stage of its cycle. It has moved -43.9% since its first surge signal on 2025-10-03, when the past-year gain stood at +66.9%.
- Since surge signal
- -43.9%
- First surge signal
- 2025-10-03
- Price at signal
- 3.03
- Past-year gain (at signal)
- +66.9%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.